455 related articles for article (PubMed ID: 30878384)
1. In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trials.
Tappenbeck N; Schröder HM; Niebergall-Roth E; Hassinger F; Dehio U; Dieter K; Kraft K; Kerstan A; Esterlechner J; Frank NY; Scharffetter-Kochanek K; Murphy GF; Orgill DP; Beck J; Frank MH; Ganss C; Kluth MA
Cytotherapy; 2019 May; 21(5):546-560. PubMed ID: 30878384
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo-expanded highly pure ABCB5
Kerstan A; Niebergall-Roth E; Esterlechner J; Schröder HM; Gasser M; Waaga-Gasser AM; Goebeler M; Rak K; Schrüfer P; Endres S; Hagenbusch P; Kraft K; Dieter K; Ballikaya S; Stemler N; Sadeghi S; Tappenbeck N; Murphy GF; Orgill DP; Frank NY; Ganss C; Scharffetter-Kochanek K; Frank MH; Kluth MA
Cytotherapy; 2021 Feb; 23(2):165-175. PubMed ID: 33011075
[TBL] [Abstract][Full Text] [Related]
3. Process data of allogeneic ex vivo-expanded ABCB5
Ballikaya S; Sadeghi S; Niebergall-Roth E; Nimtz L; Frindert J; Norrick A; Stemler N; Bauer N; Rosche Y; Kratzenberg V; Pieper J; Ficek T; Frank MH; Ganss C; Esterlechner J; Kluth MA
Stem Cell Res Ther; 2020 Nov; 11(1):482. PubMed ID: 33198791
[TBL] [Abstract][Full Text] [Related]
4. Translational development of ABCB5
Kerstan A; Dieter K; Niebergall-Roth E; Klingele S; Jünger M; Hasslacher C; Daeschlein G; Stemler L; Meyer-Pannwitt U; Schubert K; Klausmann G; Raab T; Goebeler M; Kraft K; Esterlechner J; Schröder HM; Sadeghi S; Ballikaya S; Gasser M; Waaga-Gasser AM; Murphy GF; Orgill DP; Frank NY; Ganss C; Scharffetter-Kochanek K; Frank MH; Kluth MA
Stem Cell Res Ther; 2022 Sep; 13(1):455. PubMed ID: 36064604
[TBL] [Abstract][Full Text] [Related]
5. Human skin-derived ABCB5
Hartwig V; Dewidar B; Lin T; Dropmann A; Ganss C; Kluth MA; Tappenbeck N; Tietze L; Christ B; Frank M; Vogelmann R; Ebert MPA; Dooley S
Arch Toxicol; 2019 Sep; 93(9):2645-2660. PubMed ID: 31435712
[TBL] [Abstract][Full Text] [Related]
6. ABCB5+ dermal mesenchymal stromal cells with favorable skin homing and local immunomodulation for recessive dystrophic epidermolysis bullosa treatment.
Riedl J; Pickett-Leonard M; Eide C; Kluth MA; Ganss C; Frank NY; Frank MH; Ebens CL; Tolar J
Stem Cells; 2021 Jul; 39(7):897-903. PubMed ID: 33609408
[TBL] [Abstract][Full Text] [Related]
7. Process development and safety evaluation of ABCB5
Norrick A; Esterlechner J; Niebergall-Roth E; Dehio U; Sadeghi S; Schröder HM; Ballikaya S; Stemler N; Ganss C; Dieter K; Dachtler AK; Merz P; Sel S; Chodosh J; Cursiefen C; Frank NY; Auffarth GU; Ksander B; Frank MH; Kluth MA
Stem Cell Res Ther; 2021 Mar; 12(1):194. PubMed ID: 33741066
[TBL] [Abstract][Full Text] [Related]
8. Clinical-grade human skin-derived ABCB5+ mesenchymal stromal cells exert anti-apoptotic and anti-inflammatory effects
Rendra E; Crigna AT; Daniele C; Sticht C; Cueppers M; Kluth MA; Ganss C; Frank MH; Gretz N; Bieback K
Front Immunol; 2023; 14():1228928. PubMed ID: 38274791
[TBL] [Abstract][Full Text] [Related]
9. Skin-Derived ABCB5
Niebergall-Roth E; Frank NY; Ganss C; Frank MH; Kluth MA
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613507
[TBL] [Abstract][Full Text] [Related]
10. Safety Profile of Good Manufacturing Practice Manufactured Interferon γ-Primed Mesenchymal Stem/Stromal Cells for Clinical Trials.
Guess AJ; Daneault B; Wang R; Bradbury H; La Perle KMD; Fitch J; Hedrick SL; Hamelberg E; Astbury C; White P; Overolt K; Rangarajan H; Abu-Arja R; Devine SM; Otsuru S; Dominici M; O'Donnell L; Horwitz EM
Stem Cells Transl Med; 2017 Oct; 6(10):1868-1879. PubMed ID: 28887912
[TBL] [Abstract][Full Text] [Related]
11. Newly Defined ATP-Binding Cassette Subfamily B Member 5 Positive Dermal Mesenchymal Stem Cells Promote Healing of Chronic Iron-Overload Wounds via Secretion of Interleukin-1 Receptor Antagonist.
Vander Beken S; de Vries JC; Meier-Schiesser B; Meyer P; Jiang D; Sindrilaru A; Ferreira FF; Hainzl A; Schatz S; Muschhammer J; Scheurmann NJ; Kampilafkos P; Seitz AM; Dürselen L; Ignatius A; Kluth MA; Ganss C; Wlaschek M; Singh K; Maity P; Frank NY; Frank MH; Scharffetter-Kochanek K
Stem Cells; 2019 Aug; 37(8):1057-1074. PubMed ID: 31002437
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the hepatocytic differentiation ability of human skin-derived ABCB5
Tietze L; Winkler S; Hempel M; Kluth MA; Tappenbeck N; Ganss C; Dooley S; Christ B
Exp Cell Res; 2018 Aug; 369(2):335-347. PubMed ID: 29864400
[TBL] [Abstract][Full Text] [Related]
13. ABCB5
Yan K; Zheng J; Kluth MA; Li L; Ganss C; Yard B; Magdeburg R; Frank MH; Pallavi P; Keese M
Stem Cell Res Ther; 2023 Feb; 14(1):24. PubMed ID: 36759868
[TBL] [Abstract][Full Text] [Related]
14. Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa.
Kiritsi D; Dieter K; Niebergall-Roth E; Fluhr S; Daniele C; Esterlechner J; Sadeghi S; Ballikaya S; Erdinger L; Schauer F; Gewert S; Laimer M; Bauer JW; Hovnanian A; Zambruno G; El Hachem M; Bourrat E; Papanikolaou M; Petrof G; Kitzmüller S; Ebens CL; Frank MH; Frank NY; Ganss C; Martinez AE; McGrath JA; Tolar J; Kluth MA
JCI Insight; 2021 Nov; 6(22):. PubMed ID: 34665781
[TBL] [Abstract][Full Text] [Related]
15. Processing and Ex Vivo Expansion of Adipose Tissue-Derived Mesenchymal Stem/Stromal Cells for the Development of an Advanced Therapy Medicinal Product for use in Humans.
Labedz-Maslowska A; Szkaradek A; Mierzwinski T; Madeja Z; Zuba-Surma E
Cells; 2021 Jul; 10(8):. PubMed ID: 34440677
[TBL] [Abstract][Full Text] [Related]
16. Towards an advanced therapy medicinal product based on mesenchymal stromal cells isolated from the umbilical cord tissue: quality and safety data.
Martins JP; Santos JM; de Almeida JM; Filipe MA; de Almeida MV; Almeida SC; Água-Doce A; Varela A; Gilljam M; Stellan B; Pohl S; Dittmar K; Lindenmaier W; Alici E; Graça L; Cruz PE; Cruz HJ; Bárcia RN
Stem Cell Res Ther; 2014 Jan; 5(1):9. PubMed ID: 24438697
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of Wound Development and Healing Suggests a Skin-Stabilizing Effect of Allogeneic ABCB5
Niebergall-Roth E; Dieter K; Daniele C; Fluhr S; Khokhrina M; Silva I; Ganss C; Frank MH; Kluth MA
Cells; 2023 May; 12(11):. PubMed ID: 37296590
[TBL] [Abstract][Full Text] [Related]
18. Safety and tolerability of bone marrow-derived mesenchymal stem cells in lupus animal models and a phase I clinical trial in humans.
Chun S; Choi CB; Kim MS; Nam JY; Lee TY; Lee YT; Kim S; Han SB; Bae SC
Lupus; 2022 Sep; 31(10):1245-1253. PubMed ID: 35802867
[TBL] [Abstract][Full Text] [Related]
19. Long-term detection of human adipose-derived mesenchymal stem cells after intraarticular injection in SCID mice.
Toupet K; Maumus M; Peyrafitte JA; Bourin P; van Lent PL; Ferreira R; Orsetti B; Pirot N; Casteilla L; Jorgensen C; Noël D
Arthritis Rheum; 2013 Jul; 65(7):1786-94. PubMed ID: 23553439
[TBL] [Abstract][Full Text] [Related]
20. Human mesenchymal stromal cells do not promote recurrence of soft tissue sarcomas in mouse xenografts after radiation and surgery.
Filomeno PA; Kim KP; Yoon N; Rashedi I; Dayan V; Kandel RA; Wang XH; Felizardo TC; Berinstein E; Jelveh S; Filomeno A; Medin JA; Ferguson PC; Keating A
Cytotherapy; 2018 Aug; 20(8):1001-1012. PubMed ID: 30076069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
